EN
12.03.17 Compliance

SEC investigations in the Pharmaceutical industry in China

Leaf has represented a pharmaceutical company in an investigation made by the US Department of Justice and the Securities and Exchange Commission on distribution practices in China. Negotiation with Chinese authorities regarding the same facts.

On this subject.

23.02.20
Cybersecurity for European Luxury Group and Mass Retail
23.02.20
Retail – Loi Sapin 2 / anti-corruption practice by Leaf
23.02.20
Cybersecurity on Smart Advertising in highly regulated public spaces
23.02.20
Cybersecurity for E-commerce Operators
23.02.20
Cybersecurity on the management digital systems of a leading exhibition organizer
23.02.20
Executive Liability programs
23.02.20
Corporate Social Credit in Industry and Energy
25.01.20
Cybersecurity Law Audit Related to Carsharing Software
25.01.20
Data and Cybersecurity due diligence related to M&A operations
25.01.19
Risk Analysis in Big Data Business
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Read more on our privacy policy page.